about ispe

Board of Directors

Board members can access materials for upcoming board meetings by clicking here. (Special Board member login required.)

Class of 2024

Jennifer Lund

Jennifer Lund, FISPE
Associate Professor, Department of Epidemiology
University of North Carolina at Chapel Hill
Chapel Hill, USA
Serving first 3-year term

Stine Hasling Mogensen

Stine Hasling Mogensen
Senior Advisor
Danish Medicines Agency's Data Analytic Centre
Copenhagen, Denmark
Serving first 3-year term

Daniel Prieto-Alhambra

Daniel Prieto-Alhambra, FISPE
Professor of Pharmaco- and Device Epidemiology
Centre for Statistics in Medicine
Oxford, UK
Serving first 3-year term

Yoshiaki Uyama

Yoshiaki Uyama
Director, Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA)
Tokyo, Japan
Serving first 3-year term

Hongbo Yuan

Hongbo Yuan
Scientific Advisor, Evidence Standard
Canadian Agency for Drugs and Technologies in Health
Ottawa, Canada
Serving first 3-year term

Class of 2025

Gillian Caughey

Gillian Caughey
Associate Director/Adjunct A/Professor
Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, ‎South Australian Health and Medical Research Institute
Adelaide, Australia
Serving first 3-year term

Efe Eworuke

Efe Eworuke
Associate Director, Science
Office of Pharmacovigilance and Epidemiology
Office of Surveillance and Epidemiology
Center for Drug Evaluation and Research, US FDA
Silver Spring, Maryland, USA
Serving first 3-year term

Jessica Franklin

Jessica Franklin
Principal Consultant, Epidemiology and Real-World Evidence
Optum
Boston, Massachusetts, USA
Serving first 3-year term

Ursula Kirchmayer

Ursula Kirchmayer, FISPE
Pharmacoepidemiologist
Department of Epidemiology, ASL Roma1,
Lazio Regional Health Service
Rome, Italy
Serving second 3-year term

ndrea Margulis

Andrea Margulis, FISPE‎
Director, Epidemiology RTI Health Solutions
RTI International
Barcelona, Spain
Serving first 3-year term

Class of 2026

Efe Eworuke

Keiko Asao
IQVIA Solutions Japan KK
Tokyo, Japan
Serving first 3-year term

Jessica Franklin

Marianne Cunnington
Analysis Group Inc.
London, UK
Serving first 3-year term

Mette Nørgaard
Professor in Epidemiology of Urinary Tract Diseases, Department of Clinical Epidemiology
Aarhus University
Denmark
Serving second 3-year term

Elisabetta Patorno, FISPE‎
BWH Div of Pharmacoepidemiology and Pharmacoeconomics
Boston, Massachusetts, USA
Serving first 3-year term

Jeremy Rassen, FISPE
Co-Founder, President and Chief Science Officer
Aetion, Inc.
New York, NY
Serving second 3-year term

Lifetime Emeritus

Stanley A. Edlavitch

Stanley A. Edlavitch, FISPE
University of Missouri School of Medicine
Kansas City, USA

ISPE Strategic Liaisons

  • American Society of Clinical Oncology (ASCO) / European Society for Medical Oncology (ESMO): Donna Rivera, FISPE
  • Council for International Organizations of Medical Sciences (CIOMS): Stella Blackburn, FISPE
  • Drug Information Assn (DIA): Patrice Verpillat
  • Duke Margolis Center for Health Policy: Christina Mack, FISPE
  • European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP): K. Arnold Chan, FISPE
  • Get Real Institute: Susan Oliveria, FISPE
  • International Network for Epidemiology in Policy (INEP): Susan dosReis, FISPE
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR): Shirley Wang, FISPE